Lu P, Graham L, Wang Y, Wu D, Tuszynski M
This limitation is expected to be addressed by a dedicated two-phased validation strategy in future work: Phase I Retrospective RNA Validation: This involves prioritizing an intensive search for and inclusion of any suitable independent external RNA-seq cohorts with adequate clinical follow-up data
Substituting one for another may change the peptides solubility profile, particularly for longer sequences, hydrophobic peptides, modified peptides, or peptides with specific salt forms
We discuss their structural characteristics, binding sites, and the diverse synthetic strategies employed in the design of small-molecule inhibitors
The identity of glutathione S-transferase B with ligandin, a major binding protein of liver
The key is to avoid repeated freeze-thaw cycles